metformin has been researched along with Pseudomonas Infections in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Pseudomonas Infections: Infections with bacteria of the genus PSEUDOMONAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurice, NM | 1 |
| Bedi, B | 1 |
| Yuan, Z | 1 |
| Goldberg, JB | 1 |
| Koval, M | 1 |
| Hart, CM | 1 |
| Sadikot, RT | 1 |
1 other study available for metformin and Pseudomonas Infections
| Article | Year |
|---|---|
Pseudomonas aeruginosa Induced Host Epithelial Cell Mitochondrial Dysfunction.
Topics: 4-Butyrolactone; Apoptosis; Bronchi; Cell Line; Cell Respiration; DNA Damage; DNA, Mitochondrial; Ep | 2019 |